-
Mashup Score: 0Most Read Articles - Lupus Science & Medicine - 2 year(s) ago
Discover the most frequently read articles from the past month of Lupus Science & Medicine® that have been published in the last 12 months.
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Top cited articles - Lupus Science & Medicine - 2 year(s) ago
Discover and read the most cited articles from Lupus Science and Medicine over the last 2 years.
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations - 2 year(s) ago
Objective Systemic lupus is a chronic autoimmune disease characterised by its phenotypic heterogeneity. Neutropaenia is a frequent event in SLE occurring in 20%–40% of patients depending on the threshold value of neutrophil count. On a daily basis, the management of neutropaenia in SLE is difficult with several possible causes. Moreover, the infectious consequences of neutropaenia in SLE remain…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1CD4+ T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE - 2 year(s) ago
Objective To explore cooperation between activated naïve (aNAV) B cells and CD4+ T cells in the pathogenesis of SLE through autoantibody production, T-cell differentiation and inflammatory cytokine secretion. Methods Peripheral blood mononuclear cell samples were obtained from 31 patients with SLE and used to characterise phenotype of aNAV B cells (n=14) and measured the phosphorylation of…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2
Objective Urine proteomic approaches have shown promise in identifying biological pathways in lupus nephritis (LN) which are not captured on renal histopathology or by measurement of proteinuria alone. We investigated how the urine proteome changes with treatment response and with belimumab therapy. Methods Urine samples from 54 Belimumab International Systemic Lupus Erythematosus–Lupus…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Objective It is still unclear how glucocorticoids (GCs) affect the long-term clinical course of patients with SLE. The objective of this study is to explore the factors associated with GC-free treatment status. Methods Using data from the lupus registry of nationwide institutions, GC dose at registration was compared between short, middle and long disease durations of <5, 5–20 and ≥20 years,...
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Lupus Science & Medicine: 9 (Suppl 2) - 2 year(s) ago
2022 – Volume 9 – Suppl 2 13th European Lupus Meeting, Stockholm (October 5–8, 2022) Oral communications S01.4 Belimumab disrupts memory B-cell trafficking in patients with systemic lupus erythematosus (27 September, 2022) EJ Arends, M Zlei, CM Tipton, Z Osmani, FJ De Bie, SW Kamerling, TJ Rabelink, I Sanz, JJ Van…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Lupus Science & Medicine: 9 (Suppl 2) - 2 year(s) ago
2022 – Volume 9 – Suppl 2 13th European Lupus Meeting, Stockholm (October 5–8, 2022) Oral communications S01.4 Belimumab disrupts memory B-cell trafficking in patients with systemic lupus erythematosus (27 September, 2022) EJ Arends, M Zlei, CM Tipton, Z Osmani, FJ De Bie, SW Kamerling, TJ Rabelink, I Sanz, JJ Van…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Lupus Science & Medicine: 9 (Suppl 2) - 2 year(s) ago
2022 – Volume 9 – Suppl 2 13th European Lupus Meeting, Stockholm (October 5–8, 2022) Oral communications S01.4 Belimumab disrupts memory B-cell trafficking in patients with systemic lupus erythematosus (27 September, 2022) EJ Arends, M Zlei, CM Tipton, Z Osmani, FJ De Bie, SW Kamerling, TJ Rabelink, I Sanz, JJ Van…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Background Complement activation has been associated with adverse pregnancy outcomes (APO) in SLE. Pregnant women with SLE were studied to evaluate whether complement dysregulation within the first two pregnancy trimesters predicts APO. Methods Pregnant women fulfilled classification criteria for SLE. APO included neonatal death, preterm delivery before 36 weeks and small for gestational age…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
Discover the most read articles on Lupus, Science and Medicine by going to: https://t.co/fWzS1oBPcC #LUPUS2022